APA (7th ed.) Citation

S, Y., K, F., R, K., M, I., D, H., N, T., . . . H, T. (2025). Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 31(2), 102509. https://doi.org/10.1016/j.jiac.2024.08.024

Chicago Style (17th ed.) Citation

S, Yazawa, et al. "Characteristics of Virus and Antibody Response in an Immunocompromised Patient with Persistent SARS-CoV-2 Infection." Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy 31, no. 2 (2025): 102509. https://doi.org/10.1016/j.jiac.2024.08.024.

MLA (9th ed.) Citation

S, Yazawa, et al. "Characteristics of Virus and Antibody Response in an Immunocompromised Patient with Persistent SARS-CoV-2 Infection." Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, vol. 31, no. 2, 2025, p. 102509, https://doi.org/10.1016/j.jiac.2024.08.024.